About 5 million Americans suffer from dementia -- about half of those from suspected Alzheimer's disease -- according to official estimates. Now, researchers are looking for new treatments in a field that hasn't seen a major advance since the 1960s.
Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges.
Scientists have coined a new term -- geroscience -- to describe research that aims to slow down aging and delay the onset of age-related diseases like Alzheimer's and Parkinson's. Researchers are studying the underlying genetic causes of aging and effects…
Susan Dentzer reports on early onset Alzheimer's -- a degenerative brain disease that affects an estimated 250,000 to half a million Americans -- and how a forum organized by those suffering from the diagnosis has proven an effective means of…
A new Alzheimer's Association report says the number of people with Alzheimer's is on the rise and, while elderly people still represent the vast majority of cases, as many as 500,000 people under age 65 are living with the disease.
As the number of patients stricken with Alzheimer's disease continues to grow, so does the community of families and caregivers who have pledged to look after loved ones, often risking emotional, physical and financial burdens.
An estimated 4.5 million Americans have Alzheimer's, and the number is expected to triple within 10 years. Families of patients are making efforts to push the private and public sectors toward finding better treatments.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.